September 26, 2006 UBS Global Life Sciences Conference - New York City
September 13, 2006 Avigen, Inc. Research Day, New York City
September 5, 2006 Avigen to Present at Think Equity Partners Growth Conference
July 27, 2006 Avigen Reports Second Quarter 2006 Financial Results
July 20, 2006 Avigen, Inc. Announces Second Quarter 2006 Earnings Conference Call
June 22, 2006 Avigen Initiates AV650 Clinical Development
June 12, 2006 Dutton Associates Initiates Coverage of Avigen
June 12, 2006 Avigen Announces Approval for AV411 Phase IIa Trial
June 8, 2006 Avigen to Present at Pacific Growth Equities & Needham Conferences
May 24, 2006 Avigen Announces Presentation of Data at Hemophilia 2006 World Congress
May 15, 2006 Avigen Closes $21.2 Million Private Placement of Common Stock
April 21, 2006 Avigen, Inc. Announces First Quarter 2006 Earnings Conference Call
March 30, 2006 Avigen to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
March 27, 2006 Avigen Announces Management Changes
March 21, 2006 Avigen Elects Richard Wallace to Board Of Directors
February 16, 2006 Avigen Reports 2005 Finanical Results and Reviews Development Pipeline
January 16, 2006 Avigen Licenses Unique Neuroactive Compound for Disabling Neuromuscular Conditions from Sanochemia January 10, 2006 Avigen Announces Management Change 2005 Press Releases December 21, 2005 Avigen's Gene Therapy Technology Acquired by Genzyme November 7, 2005 Avigen CEO to Present at Two Upcoming Conferences in New York October 27, 2005 Avigen Reports Results for the Three Months Ended September 30, 2005 October 18, 2005 Avigen CEO to Present at BIO InvestorForum 2005 August 5, 2005 Avigen Reports Financial Results for the Three and Six Months Ended June 30, 2005 July 18, 2005 Avigen Announces Encouraging Early Data from Parkinson's Disease Clinical Trial May 24, 2005 Avigen Collaborating with University of Colorado Pain Expert to Develop Novel Therapy to Treat Neuropathic Pain April 28, 2005 Avigen Reports Results for the Three Months Ended March 31, 2005 April 5, 2005 Avigen to Host Conference Call Today April 5, 2005 Avigen Discontinues AAV Gene Therapy Funding to Focus Exclusively on Development of Traditional Pharmaceutical Products April 1, 2005 Avigen to Present at CIBC World Markets Biotechnology and Specialty Pharmaceuticals Conference February 17, 2005 Avigen Reports 2004 Year-End Financial Results February 9, 2005 Michael Coffee Joins Avigen as Chief Business Officer
